4.3 Article

The validity and reliability of screening measures for depression and anxiety disorders in multiple sclerosis

Journal

MULTIPLE SCLEROSIS AND RELATED DISORDERS
Volume 20, Issue -, Pages 9-15

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.msard.2017.12.007

Keywords

Multiple sclerosis; Depression; Anxiety; Validity; Reliability; Psychometrics

Funding

  1. Canadian Institutes of Health Research [THC-135234]
  2. Crohn's and Colitis Canada
  3. Research Manitoba Chair
  4. Waugh Family Chair in Multiple Sclerosis
  5. Bingham Chair in Gastroenterology
  6. CIHR [333252]
  7. Research Manitoba
  8. Health and Stroke Foundation through the Manitoba Chair in Primary Prevention Research
  9. CIHR New Investigator Salary Award

Ask authors/readers for more resources

Objective: We aimed to evaluate the validity and reliability of multiple screening measures for depression and anxiety for use in the clinical care of people with multiple sclerosis (MS). Methods: Participants with MS completed the Patient Health Questionnaire (PHQ-9), Hospital Anxiety and Depression Scale (HADS), Kessler-6 Distress Scale, PROMIS Emotional Distress Depression Short-Form 8a (PROMIS Depression) and Anxiety Short-Form 8a (PROMIS Anxiety), Generalized Anxiety Disorder 7-item Scale (GAD-7), and the Overall Anxiety and Severity Impairment Scale (OASIS). A subgroup repeated the screening measures two weeks later. All participants also completed a Structured Clinical Interview for DSM-IV-TR Axis I Disorders (SCID). For the screening measures we computed sensitivity, specificity, positive predictive and negative predictive value with SCID diagnoses as the reference standard and conducted receiver operating curve (ROC) analyses; we also assessed internal consistency and test-retest reliability. Results: Of 253 participants, the SCID classified 10.3% with major depression and 14.6% with generalized anxiety disorder. Among the depression measures, the PHQ-9 had the highest sensitivity (84%). Specificity was generally higher than sensitivity, and was highest for the HADS-D with a cut-point of 11 (95%). In ROC analyses the area under the curve (AUC) did not differ between depression measures. Among the anxiety measures, sensitivity was highest for the HADS-A with a cut-point of 8 (82%). Specificity ranged from 83% to 86% for all measures except the HADS-A with a cut-point of 8 (68%). The AUC did not differ between anxiety measures. Conclusion: Overall, performance of the depression and anxiety screening measures was very similar, with reasonable psychometric properties for the MS population, suggesting that other factors such as accessibility and ease of use could guide the choice of measure in clinical practice.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available